ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,841.47
-0.02%
US Tech 100
19,750.40
0.51%
Dow Jones
43,239.05
0.37%
Brent Oil
74.08
-0.10%
Bitcoin
67,892.31
0.70%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Uniqure Nv (0EE0) Quote

Uniqure Nv

Uniqure Nv (0EE0)

LSE
31.50
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
31.50
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
31.50 52 Week Range 31.50
Market Cap
1.507B
Previous Close
31.50
Open
-
Last Trade
32
@
6.2078
(O)
Last Trade Time
15:35:43
Financial Volume
-
VWAP
-
Average Volume (3m)
4,908
Shares Outstanding
47,834,000
Dividend Yield
-
PE Ratio
-0.97
Earnings Per Share (EPS)
-6.45
Revenue
21.9M
Net Profit
-308.48M

About Uniqure Nv

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.uniqure.com
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Uniqure Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0EE0. The last closing price for Uniqure Nv was $31.50. Over the last year, Uniqure Nv shares have traded in a share price range of $ 31.50 to $ 31.50.

Uniqure Nv currently has 47,834,000 shares outstanding. The market capitalization of Uniqure Nv is $1.51 billion. Uniqure Nv has a price to earnings ratio (PE ratio) of -0.97.

Ask ADVFN Intelligence (AI)

0EE0 Latest News

More News

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V...

October 15 2024
UK Regulatory

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a...

September 23 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure...

August 15 2024
UK Regulatory

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update ~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data...

August 01 2024
UK Regulatory

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen ~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene...

July 23 2024
UK Regulatory

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease ~ Achieved statistically significant...

July 09 2024
UK Regulatory

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen ~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to...

July 01 2024
UK Regulatory

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease ~ Designation based on 24-month interim Phase I/II...

June 03 2024
UK Regulatory

uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress ~ On track to initiate FDA interaction regarding AMT-130 in second quarter of 2024 and provide a...

May 07 2024
UK Regulatory

uniQure Announces 2023 Financial Results and Highlights Recent Company Progress

uniQure Announces 2023 Financial Results and Highlights Recent Company Progress ~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington’s disease;...

February 28 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10031.531.531.51097431.5DE
40031.531.531.51129231.5DE
120031.531.531.5490831.5DE
260031.531.531.51106531.5DE
520031.531.531.5631531.5DE
1560031.531.531.5231731.5DE
2600031.531.531.5148731.5DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTCMothercare Plc
4.60p
(29.21%)
2.37M
WSBNWishbone Gold Plc
0.375p
(25.00%)
5.96M
PRIMPrimorus Investments Plc
4.25p
(21.43%)
325.18k
TRLSTrellus Health Plc
0.75p
(19.05%)
331.16k
HEMOHemogenyx Pharmaceuticals Plc
1.30p
(16.70%)
11.37M
FUTRFuture Plc
850.00p
(-13.62%)
774.04k
NFXNuformix Plc
0.055p
(-12.00%)
676.03k
JADEJade Road Investments Limited
0.175p
(-11.62%)
39.22k
INSPInspirit Energy Holdings Plc
0.0033p
(-10.81%)
14.65M
MNRGMetalnrg Plc
0.50p
(-9.09%)
48.88M
MSMNMosman Oil And Gas Limited
0.0535p
(8.30%)
353.65M
DKEDukemount Capital Plc
0.0345p
(2.99%)
171.78M
TRPTower Resources Plc
0.0295p
(-3.28%)
151.31M
BCEBeacon Energy Plc
0.0055p
(0.00%)
65.82M
PREMPremier African Minerals Limited
0.046p
(0.00%)
65.24M

Discussion

View Full Feed
Pranksalot Pranksalot 4 minutes ago
Ah I see, there’s a host of requirements. I found this on google. So shares must be at least 2 per share if they meet certain requirements but generally should be 4usd per share.

“The regular bid price of shares of the company's stock at the time of listing must be at least $4.00; ho
ELTP
The ELTP King The ELTP King 4 minutes ago
********** NEWS!!!!! **********

10/15/2024
ELITE LABS INC
OXYCODONE AND ACETAMINOPHEN ANDA #209385
SUPPL-10 Labeling - Appr
ELTP
Peter J Peter J 9 minutes ago
Sir,
So why did you do it? Why did you waste any time at all?
Within my first 10 posts you have asked me three times why I am here. Versus 14000 posts where you chose to not pop that question...

But I can tell by your posts that you have more than a passing interest in
ERHE
tkg tkg 11 minutes ago
Interesting Intel headline, off topic...

Intel seeks billions for minority stake in Altera business, sources say
*Intel is looking for an investor that would acquire at least a minority stake worth billions of dollars for its Altera subsidiary, according to sources with knowled
LWLG
RickNagra RickNagra 13 minutes ago
Oh wow. That is so ridiculous. Try $1 or more. The writing is on the wall. I mean just open your eyes. Are you a doorknob ? Seriously ? We are graded to $10 plus perhaps even $50. New products and services are coming out soon. So sit back and enjoy the rest of the day. Even though you are
BMXI
Pranksalot Pranksalot 13 minutes ago
I am not sure but I suppose that’s possible 🤷‍♂️
ELTP
The ELTP King The ELTP King 13 minutes ago
You can't get to the Nasdaq with a $1 pps.

The only way we get there is a reverse split.

https://listingcenter.nasdaq.com/assets/initialguide.pdf
ELTP
The ELTP King The ELTP King 17 minutes ago
They're just saying that in case for some reason they don't have enough time before October 21.

But he literally said that the FDA is asking for another month 😅
ELTP
carlson carlson 18 minutes ago
Gold $2,724 per OZ.Getting better and better for NBRI all the time!!!!
NBRI
Pranksalot Pranksalot 19 minutes ago
What you said makes sense but I feel that it won’t be necessary bc at this rate it will prob reach beyond 1usd by the end of the year
ELTP
$$$83 $$$83 19 minutes ago
This very good should anything positive come out of that well if that doesn't get it to move faster nothing will 🌍🌍
SEV
Frigger Frigger 21 minutes ago
Its sad that Syd can't maintain Pink status. This is not his first rodeo. He knows exactly what he is doing.
NTRR
Pranksalot Pranksalot 21 minutes ago
Now, two of the three products that I mentioned are needle movers. So let me say a few more words about that. Regarding the CMS application, the FDA asked us to make a couple of minor adjustment.
Tighten the spec, move this over here and there, nothing of relevance. But the FDA did request an
API
The ELTP King The ELTP King 25 minutes ago
The stock would be even HIGHER if we were on the Nasdaq right now. THOUSANDS of people want to invest in Elite but CAN'T because their brokerages don't allow them to invest in OTC companies. EVERYONE is complaining on Reddit that they can't buy ELTP. Imagine if all of them that wanted to buy in,
ELTP
Solarfuture Solarfuture 28 minutes ago
I was disappointed too. I hope a little that perhaps other sorts of cancer could get a faster FDA Permission...
But who knows...I will wait...
IMTX
Ppastis Ppastis 28 minutes ago
Yes, the Master Brain ( shortiepants ) has spoken again !!!!

A poster on ihub, with all this knowledge, writing BS everyday, allday … critisizing masterbrain Lebby …. More Phd’s then you have shortiepants ….

And he’s an entrepreneur … he creates something, and he will s
LWLG
Richard H2 Richard H2 30 minutes ago
Indeed, PC, those who remain obstinately in denial about the HES System now have something quite serious to contemplate regarding the purported technology. I must say, I find myself in complete agreement with The Happy Vulcan’s astute observation—specifically, his assertion that the USPTO commands c
ASRE
mwab52 mwab52 31 minutes ago
Good morning (RNVA-Land & Team).......🤑😎........Go (RNVA & Team)
RNVA
QueenVic QueenVic 32 minutes ago
...The AL SMITH dinner in NYC was an event for basically bipartisan politics.

One individual decided "not to go" 🤔

Too good for her britches? Anti Catholic?

Gee, look how people are seeing her true colors?
The ELTP King The ELTP King 33 minutes ago
I wouldn't take the chance.

There's no way the FDA can predict nearly 3 months in advance of the GDUFA date that "we need another month".

Also, Nasrat has been PURPOSELY underestimating everything lately because of what has happened in the past.

Look what
ELTP
RickNagra RickNagra 35 minutes ago
Oh wow. Just heard someone mention the great news. Unfortunately I cannot reveal the details yet because it is still not available for prime time. I must abide by the rules. But nevertheless it is yugely yuge. The only thing that is not to make me feel better about myself is that I’m going to b
DBMM
Jack Torrance Jack Torrance 36 minutes ago
Putting all this info on this board may have tipped them off and they are not answering the door now. Perhaps we should keep all this stuff private from now on. They can just come on here and see our whole strategy.
ENZC
Pranksalot Pranksalot 39 minutes ago
I am confused why he would do a stock reverse when the shares are already organically going up? Isn’t it normally a sign a company is doing poorly if they have to do a stock reverse?
ELTP
SunnyConqueror67 SunnyConqueror67 42 minutes ago
yeah, I'm also confused about his statement. may we get any clarification, king?
ELTP
Ranb2khz Ranb2khz 44 minutes ago
Who Am I – NEEDTOBREATHE (with lyrics)

[yt]miQYBclq_Pc[/yt]

https://www.youtube.com/watch?v=miQYBclq_Pc






•

Your Recent History

LSE
0EE0
Uniqure Nv
LSE
0VQR
Ubs Index Solutions Ubs Is
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved